Search clinical trials for: carboxymethylcellulose sodium based New Eye Drop Formulation 2

Total 31 results

Allergan

Completed

Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease

Dry Eye Syndromes

Canada, Australia
Allergan

Completed

A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery

Bilateral LASIK Surgery

Australia, Canada
Allergan

Completed

Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

Dry Eye Syndromes

United States
Allergan

Completed

A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

Dry Eye Disease

France, Spain, Russian Federation, Belgium, Germany, Italy, United Kingdom, Australia
Allergan

Completed

A Study to Compare a New Eye Drop Formulation With Refresh Contacts®

Contact Lens Lubrication

United States
Allergan

Completed

Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

Dry Eye Syndrome

United States
Allergan

Completed

Safety and Tolerability of Artificial Tears in Dry Eye Subjects

Dry Eye Syndrome

United States
Allergan

Completed

A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

Dry Eye Syndromes

United States
Allergan

Completed

A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.

Dry Eye Syndromes

United States, Australia
Alcon Research

Completed

A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)

Dry Eye
Alcon Research

Completed

Safety/Efficacy of Systane Free vs Refresh Liquigel

Dry Eye
Koffler Vision Group
Akorn, Inc.

Completed

Evaluation of Tear Osmolarity Over Time With Sustained Use of Thera Tears Lubricating Drops (AKORN)

Dry Eye Syndrome
Allergan

Completed

Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye

Dry Eye Syndrome

United States
Alcon Research

Completed

Fluorophotometry Evaluation of Lubricant Eye Drops

Healthy

United States
Allergan

Completed

Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery

Dry Eye Syndrome

United States
Bp Consulting, Inc

Completed

Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses

Comfort, Vision and Wear Time

United States
Allergan

Completed

Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease

Dry Eye Disease (DED)

United States
Ocugen

Completed

Dry Eye Disease Study With Brimonidine

Dry Eye

United States
University of Florida

Completed

Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome

Dry Eye Syndromes

United States
Aston University

Completed

Dry Eye Treatment With Artificial Tears

Dry Eye

United Kingdom
Allergan

Completed

Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy (IMPACT)

Dry Eye Syndromes

United States
University Health Network, Toronto

Completed

Preoperative Brimonidine on IOP of Patients Undergoing RALP (IOPsTBURG)

Prostate Cancer

Canada
Aston University
TearLab Corporation

Completed

Tear Osmolarity Clinical Utility in Dry Eye Disease

Dry Eye

United Kingdom
L.V. Prasad Eye Institute
Allergan

Recruiting

CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops

Congenital Hereditary Endothelial Dystrophy of Cornea

India
University of Waterloo
Advanced Vision Research

Completed

A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN) (DUNLIN)

Dry Eye Syndromes

Canada
Fundação Altino Ventura

Completed

Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis

Conjunctivitis, Viral

Brazil
GlaxoSmithKline
Piramal Clinical Research (Hyderabad, India)

Completed

Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions

Ulcers, Duodenal and Gastric

India
Profil Institut für Stoffwechselforschung GmbH

Completed

Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology

Type 2 Diabetes Mellitus

Germany
National Cancer Institute (NCI)

Recruiting

Testing the Addition of an Individualized Vaccine to Nab-Paclitaxel, Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma

United States
National Cancer Institute (NCI)

Suspended

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Down Syndrome | Recurrent B Acute Lymphoblastic Leukemia

United States, Canada, Puerto Rico, Australia
National Cancer Institute (NCI)

Completed

Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

United States, Canada, Australia, New Zealand, Puerto Rico

3

Subscribe